AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2015
Jul 1, 2015
31523_dirs_2015-07-01_f8a68540-e6f8-4aa8-b64b-aa1bdfbf9647.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-07-01
Reporting Person: Peist Kenneth (VP, Legal & IP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-01 | Common stock | M | 10000 | $13.9766 | Acquired | 13187 | Direct |
| 2015-07-01 | Common stock | S | 10000 | $13.9766 | Disposed | 3187 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-01 | Stock Options (right to buy) | $4.38 | M | 10000 | Disposed | 2022-06-04 | Common Stock (10000) | Direct |
Footnotes
F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
F2: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.86 to $14.10. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.86 to $14.10. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.